New Driver Mutations Detected in NSCLC

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2016-074
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

P2.02-018 Genomic Profiling of Driver Gene Mutations in 498 Chinese NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Driver Mutations in Melanoma

Libri Oncologici
Oncology
2018English

MA04.03 Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) With Oncogenic Driver Mutations: New Results From the Global IMMUNOTARGET Registry

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Somatic Driver Mutations in Melanoma

Cancer
Cancer ResearchOncology
2017English

P1.01-67 Clinical Relevance of ALK/ROS1 Resistance Mutations and Other Acquired Mutations Detected by Liquid Biopsy in Advanced NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Targetable Driver Mutations in Multicentric Reticulohistiocytosis

Haematologica
Hematology
2019English

ARID1A Gene Driver Mutations in Lung Adenocarcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Allostery Modulates Resistance Driver Mutations in TEM-1

Biophysical Journal
Biophysics
2019English

P1.09-06 the Incidence of PD-L1 in NSCLC and Its Correlation With Driver Mutations in Turkish Patients; A Single Center Experience

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy